Compelling evidence for a significant role of the CXCL8-CXCR1/2 axis in T1D gleaned from in vivo studies of CXCR1/2 blockade in preclinical models is underscored by further discoveries about neutrophil actions in this context. This evidence concerns the gene CXCR1 and type 1 diabetes mellitus.